Results

1–3 of 3 results for cost analysis

Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019
Episode 160: Retinal Detachment Cost Analysis and Trainee Surgery with Dr. Jay Stewart
Jayanth Sridhar, MD
Member Podcasts
2018